Search
Hot topics close

Remdesivir

gilead stock
41
  • COVID-19 drug remdesivir priced at $390 per vial for some patients, $520 for others
  • COVID-19 Drug Remdesivir Priced At More Than $3,100 Per Patient : Shots - Health News
  • Remdesivir, the First Coronavirus Drug, Gets a Price Tag
  • Gilead sets price of coronavirus drug remdesivir at $3,120 as Trump administration secures supply for 500,000 patients
  • Remdesivir for coronavirus: Gilead to charge thousands for treatment in U.S.
  • Here's how much Covid-19 drug remdesivir will cost
  • Coronavirus drug remdesivir to cost $3,120 per patient with private insurance
  • Gilead announces long-awaited price for Covid-19 drug remdesivir
  • Gilead’s remdesivir improves recovery time of coronavirus patients in NIH trial
  • Coronavirus Treatment: GILD Stock Pops On Positive Test Results
  • Remdesivir Speeds Recovery From COVID-19 In Preliminary Trial Results : Shots - Health News
  • Study: Remdesivir appears to speed recovery times in hospitalized COVID-19 patients
  • Remdesivir may change the fight against coronavirus
  • Remdesivir: Drug has 'clear cut' power to fight coronavirus
  • Remdesivir shows success in large COVID-19 trial. Will become 'new standard of care,' Fauci says.
  • Fauci expresses optimism about 'significant, positive' data from a trial of the possible Covid-19 treatment remdesivir
  • Gilead soars 11% after reporting positive news on potential coronavirus treatment (GILD)
  • Gilead reports early positive data in remdesivir studies as COVID-19 drug, though Chinese trial sees no benefit
  • 'Clear-cut' evidence coronavirus drug remdesivir works, Fauci says
  • Gilead says early results of coronavirus drug trial show improvement with shorter remdesivir treatment